258 results on '"Tao, Xufeng"'
Search Results
2. Global Burden of Disease Study 2019 Indicates That Smoking Gradually Becomes a Key Driver of the Burden of Pancreatic Cancer in Developing Regions
3. Advances in targeted therapy for pancreatic cancer
4. Global trends and partial forecast of adverse effects of medical treatment from 1990 to 2019: an epidemiological analysis based on the global burden of disease study 2019
5. Letter to the editor “Pharmacologic prevention and therapy of postoperative paralytic ileus after gastrointestinal cancer surgery – systematic review and meta-analysis”
6. ROS in hepatocellular carcinoma: What we know
7. Application of Internet of Things Technology in the Field of Environmental Engineering
8. Metabolic reprogramming of immune cells in pancreatic cancer progression
9. Berberine inhibits pancreatic intraepithelial neoplasia by inhibiting glycolysis via the adenosine monophosphate -activated protein kinase pathway
10. Application of Internet of Things Technology in the Field of Environmental Engineering
11. Serotonin-RhoA/ROCK axis promotes acinar-to-ductal metaplasia in caerulein-induced chronic pancreatitis
12. Corrigendum to “Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis” [Pharm. Res. 108 (2016) 90–101]
13. Retraction Note: Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β
14. MicroRNAs in Pancreatic Cancer and Chemoresistance
15. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal
16. The crosstalk between microbiota and metabolites in AP mice: an analysis based on metagenomics and untargeted metabolomics
17. Machine Learning Techniques Applied to the Study of Drug Transporters
18. Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
19. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation
20. Dioscin, a potent ITGA5 inhibitor, reduces the synthesis of collagen against liver fibrosis: Insights from SILAC-based proteomics analysis
21. Application of aptamer-drug delivery system in the therapy of breast cancer
22. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
23. Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1
24. LMIBE: Lattice-Based Matchmaking Identity-Based Encryption for Internet of Things
25. Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms
26. Health Impacts of High BMI in China: Terrible Present and Future
27. List of Contributors
28. Dioscin as a Natural Saponin and Protection in Oxidative Stress in Hepatic Fibrosis
29. Macrophages: A rising star in immunotherapy for chronic pancreatitis
30. Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets
31. Contemporary Chinese dietary pattern: Where are the hidden risks?
32. Relationship between metabolic reprogramming and drug resistance in breast cancer
33. Activated Pancreatic Stellate Cells Promote Acinar Duct Metaplasia by Disrupting Mitochondrial Respiration and Releasing Reactive Oxygen Species
34. Berberine inhibits the proliferation of pancreatic cancer cells by targeting pancreatic cancer stem cells through regulating EMT signaling pathway
35. Corrigendum to “Protective effect of dioscin against intestinal ischemia/reperfusion injury via adjusting miR-351-5p-mediated oxidative stress” [Pharmacol. Res. 137 (2018) 56–63]
36. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway
37. Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis
38. S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
39. Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence
40. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition
41. Berberine inhibits the proliferation of pancreatic cancer targeting pancreatic cancer stem cells
42. A New Panel of Pancreatitis-Related LncRNAs is a Diagnostic Marker of Pancreatic Cancer
43. Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation
44. RETRACTED ARTICLE: Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β
45. Corrigendum to “Protective effects of dioscin agains doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation” [Toxicology 378 (2017) 53–64]
46. Obg-Like ATPase 1 Enhances Chemoresistance of Breast Cancer via Activation of TGF-β/Smad Axis Cascades
47. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
48. Correction: Zhao, X.W., et al. Dioscin Induces the Apoptosis of Human Cervical Carcinoma HeLa and SiHa Cells Through ROS-mediated DNA Damage, Cell Cycle Arrest and Mitochondrial Signaling Pathways. Molecules 2016, 21, 730
49. Corrigendum to “Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis” [Pharmacol. Res. 108 (2016) 90–101]
50. Correction: Zhao, L.S., et al. Protective Effect of the Total Flavonoids from Rosa laevigata Michx Fruit on Renal Ischemia–Reperfusion Injury through Suppression of Oxidative Stress and Inflammation. Molecules 2016, 21, 952.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.